UNQ;PRO;TRDL;ZTNF;UNQ383/PRO;TNF-related death ligand;Tumor necrosis factor ligand superfamily member;TNF- and APOL-related leukocyte expressed ligand;TNFSF;TNFSF13;APRIL;CD256;TALL-2;TALL2;TNLG7B;TRDL-1;UNQ383/PRO715;ZTNF2;A proliferation-inducing ligand;TNF- and APOL-related leukocyte expressed ligand 2;TNF-related death ligand 1;Tumor necrosis factor ligand superfamily member 13;UNQ383;PRO715; TALL-2; TNFSF13;A proliferation inducing ligand;member 13;TNF related death ligand;TNF13;TRDL1;Tumor necrosis factor (ligand) superfamily;Tumor necrosis factor like protein ZTNF2;Tumor necrosis factor related death ligand 1

HEK293 Cells

Lys112-Leu250

O75888

Human

50.0 kDa

60 kDa

N-Flag-His

Not validated for activity

> 95 % as determined by reducing SDS-PAGE.

< 1.0 EU per μg of the protein as determined by the LAL method.

Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

This product is provided as lyophilized powder which is shipped with ice packs.

Lyophilized from a 0.2 μm filtered solution of 20mM PB, 1M NaCl, pH8.3.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Please refer to the printed manual for detailed information.

APRIL (a proliferation-inducingligand), also known as TNFSF13, TALL2, TRDL1, and CD256, is a member of the TNF ligand superfamily. It is synthesized as a32 kDa proprotein which is cleaved by furin in the Golgi to release the active 17 kDa soluble molecule. Secreted human APRIL, which consists almost entirely ofa single TNF homology domain, shares 85% amino acid sequence identity with mouse and rat APRIL. Both APRIL and its close relative BAFF bind and signalthrough the TNF superfamily receptors TACI and BCMA, while BAFF additionally functions through BAFF R. APRIL binds to heparan sulfateproteoglycans (HSPGs) independently of its binding to TACI and BCMA. APRIL can form bioactive heterotrimers withBAFF, and these circulate in the serum of patients with rheumatic immune disorders. APRIL enhances the proliferation and survival of plasma cells andalso promotes T cell-dependenthumoral responses. APRIL levels are elevated inthe serum during coronary artery disease, and it is also elevated in many cancers primarily due to expression by tumor-infiltratingneutrophils.